Nonalcoholic fatty liver disease (NAFLD) and diabetes mellitus are common diseases that
often coexist and might act synergistically to increase the risk of hepatic and extra-hepatic …

Context: Nonalcoholic fatty liver disease (NAFLD) is increasingly diagnosed worldwide and
is the most common chronic liver disease in Western countries. In this review, we discuss the …

Non-alcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of
metabolic syndrome. To date, NAFLD is the most frequent chronic liver disease seen day by …

BACKGROUND & AIMS: To estimate the prevalence of non-alcoholic fatty liver disease
(NAFLD) in type 1 diabetic individuals, and to evaluate whether NAFLD is associated with …

Abstract Purpose of Review Nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes
mellitus (T2DM) are strongly associated. Both also associate with an increased risk of …

OBJECTIVE—To determine the prevalence of nonalcoholic fatty liver disease (NAFLD) in
type 2 diabetic population and to compare the prevalence of cardiovascular disease (CVD) …

Non-alcoholic fatty liver disease (NAFLD) has become one of the most common forms of
chronic liver disease worldwide and its prevalence is expected to continue rising. NAFLD …

Background Nonalcoholic fatty liver disease (NAFLD) has been linked to an increased risk
of cardiovascular disease (CVD). To explore the impact of diabetes mellitus (DM) as a …

Nonalcoholic fatty liver disease (NAFLD) is prevalent in people with the metabolic syndrome
and type 2 diabetes and is present in up to one‐third of the general population. Evidence is …

Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD) are two
diseases that are common in the general population. To date, many studies have been …